术前哨兵淋巴结超声造影如何辅助乳腺癌术中哨兵淋巴结活检:初步经验
研究纳入2015年6月至2017年12月453例早期浸润性乳腺癌患者,术前经乳晕皮内注射微泡造影剂行哨兵淋巴结超声造影(SLN-CEUS)并用龙胆紫体表标记,术中与蓝染料法对比。SLN-CEUS与蓝染料法对淋巴管和哨兵淋巴结的符合率为98.2%,SLN-CEUS诊断哨兵淋巴结的敏感度96.82%、特异度91.91%、阳性预测值87.54%、阴性预测值98.01%。作者认为SLN-CEUS可作为蓝染料法的有效补充。
要点
- 术前SLN-CEUS联合体表标记可识别淋巴管走行和哨兵淋巴结位置,与术中蓝染料法符合率98.2%。
- SLN-CEUS诊断哨兵淋巴结的敏感度96.82%、特异度91.91%、阳性预测值87.54%、阴性预测值98.01%。
- SLN-CEUS测得哨兵淋巴结至皮肤中位距离与蓝染料法无显著差异(1.95±0.69 cm vs 2.03±0.87 cm,p=0.35)。
核心结论
- SLN-CEUS联合体表标记可在术前识别淋巴管走行和哨兵淋巴结位置、测量哨兵淋巴结至皮肤距离并判断哨兵淋巴结是否转移,可作为蓝染料法的有效补充。
研究设计与样本
- 2015年6月至2017年12月招募453例早期浸润性乳腺癌患者,术前一天经乳晕皮内注射微泡造影剂行SLN-CEUS并用龙胆紫体表标记淋巴管和哨兵淋巴结位置,术前半小时注射双重蓝染料,术中对比SLN-CEUS与蓝染料法显示的淋巴管路径和哨兵淋巴结位置。
关键影像表现/征象
- SLN-CEUS检出淋巴管平均数目1.42、哨兵淋巴结平均数目1.72,与术中蓝染料法符合率98.2%。
- SLN-CEUS测得哨兵淋巴结至皮肤中位距离1.95±0.69 cm,蓝染料法2.03±0.87 cm,两者无显著差异(p=0.35)。
- 哨兵淋巴结增强模式包括均匀增强、不均匀增强和无增强三种。
诊断标准与关键数值
- SLN-CEUS诊断哨兵淋巴结的敏感度96.82%、特异度91.91%、阳性预测值87.54%、阴性预测值98.01%。
- SLN-CEUS与术中蓝染料法对淋巴管路径和哨兵淋巴结位置的符合率为98.2%。
临床应用与阅片要点
- 术前SLN-CEUS联合体表龙胆紫标记可识别淋巴管走行和哨兵淋巴结位置,供术中活检参考。
- SLN-CEUS可测量哨兵淋巴结至皮肤距离,并判断哨兵淋巴结是否转移。
- 作者认为SLN-CEUS可作为蓝染料法的有效补充。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
We aimed to evaluate the value of sentinel lymph node contrast-enhanced ultrasound (SLN-CEUS) and surface tracing for the biopsy of intra-operative sentinel lymph nodes (SLNs). Between June 2015 and December 2017, a total of 453 patients with early invasive breast cancer were recruited. Patients received an intradermal injection of microbubble contrast agent around the areola on the day before surgery. The locations and sizes of lymphatic channels (LCs) and SLNs were marked on the body surface using gentian violet. Then, injection of double blue dye was performed half an hour before surgery. We compared the pathway of LCs and the location of SLNs obtained from SLN-CEUS and blue dye during surgery. Among the 453 patients, the mean numbers of LCs and SLNs detected by SLN-CEUS were 1.42 and 1.72, respectively, and the coincidence rate was 98.2% compared with blue dye during surgery. The median distance from the SLN to skin measured by pre-operative CEUS and blue dye was 1.95 ± 0.69 and 2.03 ± 0.87 cm (p = 0.35). There were three SLN enhancement in our research, including homogeneous enhancement, inhomogeneous enhancement and no enhancement, with the sensitivity, specificity, positive predictive value and negative predictive value of SLN-CEUS for the diagnosis of SLNs being 96.82%, 91.91%, 87.54% and 98.01%, respectively. SLN-CEUS with skin marking can identify the pathway of LCs and the location of the SLN before surgery, measure the distance from the SLN to skin and determine if the SLN is metastatic. SLN-CEUS can be used as an effective complement to the blue dye method.
引用
- Li J, Lu M, Cheng X, et al. How Pre-operative Sentinel Lymph Node Contrast-Enhanced Ultrasound Helps Intra-operative Sentinel Lymph Node Biopsy in Breast Cancer: Initial Experience. Ultrasound Med Biol. 2019. PMID: 31101445. doi:10.1016/j.ultrasmedbio.2019.04.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。